Anterior Quadratus Lumborum Block as a Component of Multimodal Analgesia for Abdominal Hysterectomies

Launched by YURI SEMENYUK RIVNE REGIONAL CLINICAL HOSPITAL · Jun 23, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new way to manage pain for women having abdominal hysterectomy surgery, which is the removal of the uterus often done for conditions like fibroids or other uterine problems. The researchers want to see if adding a special type of nerve block called an anterior quadratus lumborum (QL) block before surgery can help reduce the amount of opioid pain medication needed during and after the operation, lower pain levels, and improve overall recovery.

Women who are generally healthy (classified as ASA I or II) and have symptoms from fibroids or other uterine conditions, and are scheduled for an abdominal hysterectomy, may be eligible to take part. Participants will receive standard general anesthesia during surgery, and some will also get the QL nerve block while others will not, but neither the patients nor the doctors will know who gets the block during the study. This is to fairly test if the nerve block makes a difference. Important to note, women with very high body weight, uncontrolled high blood pressure, those already using certain opioid medications, or those who don’t want to participate will not be included. The trial is not yet recruiting, but if you qualify, you can expect careful monitoring of your pain and recovery after surgery to see if this nerve block helps improve your comfort and healing.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • patients with ASA status I-II
• • patients with symptomatic fibroids
• • patients scheduled for abdominl hysterectomy
• Exclusion Criteria:
• • refusal to participate in the study at any of its stages
• • ASA class ≥ III
• • body mass index \> 40 kg/m2
• • use of opiate receptor agonists/antagonists before surgery
• • uncontrolled hypertension